Univariate Kaplan-Meier survival analysis of the complete CRC patients (n = 95) based on TSP50 expression demonstrated that the disease-specific survival period was significantly shorter for patients with high TSP50 expression than for patients with low TSP50 expression (log-rank P = 0.010; Figure 5A). The gene discussed is PRSS50; the disease is colorectal carcinoma.